PMC:7461420 / 108968-109750 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T2","span":{"begin":590,"end":595},"obj":"https://glytoucan.org/Structures/Glycans/G00052MO"}],"text":" Thanigaimalai Pillaiyar received his doctoral degree in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang‐Hun Jung at Chungnam National University, South Korea. In 2011, he won a “Japanese Society for the Promotion of Science Postdoctoral Fellowship (JSPS)” for 2 years with Prof. Dr. Yoshio Hayashi at Tokyo University of Pharmacy and Life Sciences, Japan. He was awarded an Alexander von Humboldt postdoctoral fellowship (AvH) in 2013 for 2 years with Prof. Dr. Christa E. Müller at University of Bonn, Germany. He worked as a visiting scientist at the Prof. Steven V. Ley's Laboratory, Department of Chemistry, and University of Cambridge. Currently he is working on developing modulators/inhibitors for SARS‐CoV‐2 Mpro and various G‐protein‐coupled receptors."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":754,"end":763},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma61788"}],"text":" Thanigaimalai Pillaiyar received his doctoral degree in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang‐Hun Jung at Chungnam National University, South Korea. In 2011, he won a “Japanese Society for the Promotion of Science Postdoctoral Fellowship (JSPS)” for 2 years with Prof. Dr. Yoshio Hayashi at Tokyo University of Pharmacy and Life Sciences, Japan. He was awarded an Alexander von Humboldt postdoctoral fellowship (AvH) in 2013 for 2 years with Prof. Dr. Christa E. Müller at University of Bonn, Germany. He worked as a visiting scientist at the Prof. Steven V. Ley's Laboratory, Department of Chemistry, and University of Cambridge. Currently he is working on developing modulators/inhibitors for SARS‐CoV‐2 Mpro and various G‐protein‐coupled receptors."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T517","span":{"begin":189,"end":191},"obj":"Disease"},{"id":"T518","span":{"begin":672,"end":674},"obj":"Disease"},{"id":"T519","span":{"begin":726,"end":730},"obj":"Disease"}],"attributes":[{"id":"A517","pred":"mondo_id","subj":"T517","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"},{"id":"A518","pred":"mondo_id","subj":"T518","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"},{"id":"A519","pred":"mondo_id","subj":"T519","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" Thanigaimalai Pillaiyar received his doctoral degree in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang‐Hun Jung at Chungnam National University, South Korea. In 2011, he won a “Japanese Society for the Promotion of Science Postdoctoral Fellowship (JSPS)” for 2 years with Prof. Dr. Yoshio Hayashi at Tokyo University of Pharmacy and Life Sciences, Japan. He was awarded an Alexander von Humboldt postdoctoral fellowship (AvH) in 2013 for 2 years with Prof. Dr. Christa E. Müller at University of Bonn, Germany. He worked as a visiting scientist at the Prof. Steven V. Ley's Laboratory, Department of Chemistry, and University of Cambridge. Currently he is working on developing modulators/inhibitors for SARS‐CoV‐2 Mpro and various G‐protein‐coupled receptors."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T54","span":{"begin":196,"end":197},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T55","span":{"begin":546,"end":547},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T56","span":{"begin":754,"end":781},"obj":"http://purl.obolibrary.org/obo/PR_000030035"}],"text":" Thanigaimalai Pillaiyar received his doctoral degree in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang‐Hun Jung at Chungnam National University, South Korea. In 2011, he won a “Japanese Society for the Promotion of Science Postdoctoral Fellowship (JSPS)” for 2 years with Prof. Dr. Yoshio Hayashi at Tokyo University of Pharmacy and Life Sciences, Japan. He was awarded an Alexander von Humboldt postdoctoral fellowship (AvH) in 2013 for 2 years with Prof. Dr. Christa E. Müller at University of Bonn, Germany. He worked as a visiting scientist at the Prof. Steven V. Ley's Laboratory, Department of Chemistry, and University of Cambridge. Currently he is working on developing modulators/inhibitors for SARS‐CoV‐2 Mpro and various G‐protein‐coupled receptors."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20456","span":{"begin":711,"end":721},"obj":"Chemical"},{"id":"T20923","span":{"begin":756,"end":763},"obj":"Chemical"}],"attributes":[{"id":"A90954","pred":"chebi_id","subj":"T20456","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A67424","pred":"chebi_id","subj":"T20923","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":" Thanigaimalai Pillaiyar received his doctoral degree in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang‐Hun Jung at Chungnam National University, South Korea. In 2011, he won a “Japanese Society for the Promotion of Science Postdoctoral Fellowship (JSPS)” for 2 years with Prof. Dr. Yoshio Hayashi at Tokyo University of Pharmacy and Life Sciences, Japan. He was awarded an Alexander von Humboldt postdoctoral fellowship (AvH) in 2013 for 2 years with Prof. Dr. Christa E. Müller at University of Bonn, Germany. He worked as a visiting scientist at the Prof. Steven V. Ley's Laboratory, Department of Chemistry, and University of Cambridge. Currently he is working on developing modulators/inhibitors for SARS‐CoV‐2 Mpro and various G‐protein‐coupled receptors."}

{"project":"LitCovid-sentences","denotations":[{"id":"T999","span":{"begin":1,"end":179},"obj":"Sentence"},{"id":"T1000","span":{"begin":180,"end":376},"obj":"Sentence"},{"id":"T1001","span":{"begin":377,"end":493},"obj":"Sentence"},{"id":"T1002","span":{"begin":494,"end":532},"obj":"Sentence"},{"id":"T1003","span":{"begin":533,"end":589},"obj":"Sentence"},{"id":"T1004","span":{"begin":590,"end":661},"obj":"Sentence"},{"id":"T1005","span":{"begin":662,"end":782},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Thanigaimalai Pillaiyar received his doctoral degree in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang‐Hun Jung at Chungnam National University, South Korea. In 2011, he won a “Japanese Society for the Promotion of Science Postdoctoral Fellowship (JSPS)” for 2 years with Prof. Dr. Yoshio Hayashi at Tokyo University of Pharmacy and Life Sciences, Japan. He was awarded an Alexander von Humboldt postdoctoral fellowship (AvH) in 2013 for 2 years with Prof. Dr. Christa E. Müller at University of Bonn, Germany. He worked as a visiting scientist at the Prof. Steven V. Ley's Laboratory, Department of Chemistry, and University of Cambridge. Currently he is working on developing modulators/inhibitors for SARS‐CoV‐2 Mpro and various G‐protein‐coupled receptors."}